Follicular carcinoma of the thyroid gland: Prognostic factors, treatment, and survival

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 1, 2000, Pages 1-5

  Zidan, Jamal ^a,b   Kassem, Samer ^b   Kuten, Abraham ^b  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Follicular carcinoma of thyroid; Prognostic factors; Survival; Treatment

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER INVASION; CANCER SURVIVAL; FEMALE; GENDER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SUBTOTAL THYROIDECTOMY; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0034123678     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200002000-00001     Document Type: Article

References (31)

1. Emerick GT, Duh QY, Siperstein AE, et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 1993;72: 3287-95.
2. Mazzaferri EL. Papillary thyroid carcinoma. Factors influencing prognosis and current therapy. Semin Oncol 1987;14:315-32.
3. Vigneri R. Studies on the goiter endemic in Sicily. J Endocrinol Invest 1988;11:831-43.
4. Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184:541-53.
5. Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 1987;8:479-88.
6. Hamming JF, Van de Velde CJ, Goslings BM, et al. Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol 1989;25:1317-23.
7. Woolner LB. Thyroid carcinoma: pathologic classification with data on prognosis. Semin Nucl Med 1971;1:481-502.
8. Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 1980;21:733-7.
9. Harness JK, Thompson NW, McLeod MK, et al. Follicular carcinoma of the thyroid gland: trends and treatment. Surgery 1984;96: 972-80.
10. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC thyroid cancer cooperative group. Eur J Cancer 1979;15:1033-41.
11. Hurley A, Becker DV. The use of radioiodine in the management of thyroid cancer. Nuclear medicine annual 1983. New York, NY: Raven Press, 1983:329-84.
12. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
13. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathological findings, therapy, and outcome. Mayo Clin Proc 1991;66:11-22.
14. American Joint Committee on Cancer. Thyroid gland. Manual for staging of cancer. 5th ed. Philadelphia: JB Lippincott, 1997:47-50.
15. 131I. JAMA 1970;214:1437-42.
16. Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160: 344-7.
17. Hamming JF, Van de Velde CJ, Goslings BM, et al. Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol 1989;25:1317-23.
18. Donohue JH, Goldfien SD, Miller TR, et al. Do the prognoses of papillary and follicular thyroid carcinomas differ? Am J Surg 1984;148:168-73.
19. Crile G Jr, Pontius KI, Hawk WA. Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gynecol Obstet 1985;160:409-13.
20. Schelfhout LJ, Creutzberg CL, Hamming JF, et al. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988;24: 331-7.
21. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas: a retrospective follow-up study covering a 14 year period with emphasis on morphological findings. Am J Surg Pathol 1986;10:246-55.
22. Brooks JR, Starnes HF, Brooks DC, Pelkey JN. Surgical therapy for thyroid carcinoma: a review of 1249 solitary thyroid nodules. Surgery 1988;104:940-6.
23. Kerr DJ, Burt AD, Boyle P, et al. Prognostic factors in thyroid tumors. Br J Cancer 1986;54:475-82.
24. Hrafnkelsson J, Jonasson JG, Sigurdsson G, et al. Thyroid cancer in Iceland 1955-1984. Acta Endocrinol Copenh 1988;118:566-72.
25. Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer 1986;58:1749-55.
26. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53.
27. Beierwaltes WH, Nishiyama RH, Thompson NW, et al. Survival time and "cure" in papillary and follicular carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982;23:561-8.
28. Block BL, Spiegel JC, Chami RG. The treatment of papillary and follicular carcinoma of the thyroid. Otolaryngol Clin North Am 1990;23:403-11.
29. Clark OH, Levin K, Zeng QH, et al. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin Oncol 1988;24:305-13.
30. LiVolsi VA, Asa SL. The demise of follicular carcinoma of thyroid gland. Thyroid 1994;4:233-6.
31. Maxon HR, Englaro EE 3rd, Thomas SR, et al. Radioiodine-131 therapy for well differentiated thyroid cancer - a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992;33:1132-6.